Developer docs
API playgroundTry for free, no card

Search company profiles

Perceptive

Full company profile

uuid0008s8n

Namestring
Perceptive
Legal namestring
Perceptive
Websiteurl
perceptive.com
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Perceptive is a privately held, science-led clinical research services provider headquartered in London, with operations spanning preclinical imaging, clinical trial imaging, and randomization and trial supply management (RTSM). The company is organized into three operating divisions — Perceptive Discovery (preclinical imaging, radiochemistry, biodistribution, and binding assays), Perceptive eClinical (IRT/RTSM, with the ClinPhone Pro platform, plus eCOA and Clinical Intelligence), and Perceptive Imaging (imaging core lab and in-house imaging centers in London and New Haven). Its technology stack combines proprietary software (VivoQuant for preclinical image analysis, ClinPhone Pro for cloud-native RTSM, and iPACS for workflow management) with multi-modality imaging capabilities across PET, SPECT, MRI, CT, and optical platforms, and GMP radiotracer manufacturing.

The company serves global biopharmaceutical sponsors and CROs, with a strong specialty focus on radiopharmaceutical therapy and theranostics (supporting 80% of radioligand therapy companies), oncology (1,800+ solid tumor trials), CNS (770+ trials), and rare diseases. It has supported 11,000+ trials, 800+ regulatory approvals across FDA, EMA, and NMPA, and randomized 3M+ participants through its IRT systems. Named customers include ArriVent, LG Chem, Veralox Therapeutics, ClinChoice, and ProTrials. Distribution is enterprise-direct with CRO channel partnerships, and services are quote-based professional engagements plus recurring platform subscriptions on ClinPhone Pro.

Revenue is not publicly disclosed. Growth is being driven by a cluster of recent moves: the May 2025 launch of ClinPhone Pro, a January 2026 $15M investment from CapVest, and 2026 alliances with Trialzen (clinical supply intelligence), Kayentis (eCOA), and MH3D (α-Sight alpha radiopharmaceutical imaging), alongside a 5x expansion of its Needham preclinical lab. The company maintains a zero-observation regulatory inspection record over the past decade and is recognized as the #1 Market Impact leader in Everest Group's 2025 PEAK Matrix for RTSM Solutions.

Short descriptiontext

Perceptive is a London-based clinical research services provider offering preclinical imaging, clinical trial imaging, and IRT/RTSM solutions to global biopharmaceutical sponsors and CROs, with deep specialization in radiopharmaceutical therapy and oncology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial imaging, preclinical imaging services, randomization trial supply, medical imaging core lab, radiochemistry services
Industry2 codes
PRIMARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Other Scientific and Technical Consulting Services541690
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Clinical Imaging Core Lab Services
TypeProfessional Services
Description

Fees for clinical trial imaging services including centralized blinded independent reads, quantitative image analysis, site qualification and training, and regulatory-compliant data management across all phases of clinical development.

perceptive.com
2IRT/RTSM Technology and Services
TypeSubscription Recurring
Description

Interactive Response Technology platform and randomization services for clinical trials, supporting all phases and therapeutic areas with dedicated project management and consultancy.

perceptive.com
3Preclinical Imaging and Radiochemistry Services
TypeProfessional Services
Description

Discovery-phase imaging services including biodistribution studies, efficacy modeling, dosimetry, and radiolabeling services for drug development programs.

perceptive.com
4Clinical Intelligence Consultancy
TypeProfessional Services
Description

Technology-enabled consultancy service combining clinical supply expertise with advanced forecasting technology, generating reported savings exceeding $1 million per study for sponsors.

eqs-news.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1ClinPhone Pro
Description

Next-generation IRT/RTSM platform for clinical trial randomization and supply management

perceptive.com
+3 more records
Core offering1 text field

Perceptive delivers preclinical and clinical medical imaging core lab services, randomization and trial supply management (IRT/RTSM) via the ClinPhone Pro platform, electronic clinical outcome assessments (eCOA), radiochemistry, biodistribution and radioligand binding assay services, and clinical trial adjudication for pharmaceutical, biotechnology, and medical device sponsors. The company supports more than 11,000 trials and 800 regulatory approvals with a workforce of 3,000+ professionals across its integrated preclinical-to-clinical continuum.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Real-world engagements generating savings exceeding $1 million per study through clinical supply optimization
+4 more records
Product overview1 text field

Perceptive is a science-led provider offering preclinical imaging, clinical trial imaging, and randomization and trial supply management (RTSM) services. The company's product portfolio consists of three interconnected service pillars: (1) Discovery/Preclinical services including Preclinical Imaging, Radiochemistry, Biodistribution Services, and Radioligand Binding Assay Services; (2) eClinical solutions including IRT/RTSM (ClinPhone Pro platform), eCOA module, and Clinical Intelligence consultancy; and (3) Clinical Imaging services including Imaging Core Lab and In-House Clinical and Imaging Centers. Supporting these core offerings is the VivoQuant™ software platform for preclinical image analysis. The integrated ecosystem enables sponsors to move from early discovery through late-phase clinical trials, with specialized expertise in oncology, CNS, radiopharmaceutical therapy, and rare diseases.

Product and service9 records
1Clinical Imaging Core Lab
CategoryClinical Research Services
Description

Centralized medical imaging core lab services for clinical trials, including image acquisition standards, blinded independent central review, and quantitative endpoint analysis for pharmaceutical and biotech sponsors across therapeutic areas including oncology.

2Preclinical Imaging
CategoryPreclinical Research Services
Description

Preclinical imaging services and image analysis software (VivoQuant) supporting early-stage drug development, biodistribution studies, and translational research for pharmaceutical and biotech R&D teams.

3IRT/RTSM (ClinPhone Pro)
CategoryClinical Trial Software
Description

Randomization and Trial Supply Management (IRT/RTSM) software platform used to randomize patients, manage drug supply logistics, and maintain blinding in clinical trials for pharmaceutical and biotech sponsors.

4Electronic Clinical Outcome Assessment (eCOA)
CategoryClinical Trial Software
Description

Electronic Clinical Outcome Assessment platform for capturing patient-reported outcomes, clinician-reported outcomes, and performance outcomes in clinical trials, deployed for pharmaceutical and biotech sponsors.

5Radiochemistry Services
CategorySpecialty Research Services
Description

Specialized radiochemistry services supporting the development and manufacture of radiolabeled compounds for imaging and radioligand therapy studies in clinical and preclinical development.

6Biodistribution Services
CategorySpecialty Research Services
Description

Biodistribution studies and analyses, including quantitative tissue distribution assessments, supported by the α-Sight workflow tool, for sponsors developing radiopharmaceuticals and imaging agents.

7Radioligand Binding Assay Services
CategorySpecialty Research Services
Description

Radioligand binding assay services supporting in vitro characterization of receptor-ligand interactions for radiopharmaceutical and central nervous system drug development programs.

8Clinical Trial Adjudication Services
CategoryClinical Research Services
Description

Independent endpoint adjudication committee management and event adjudication services for clinical trials requiring blinded expert review of safety or efficacy events.

9In-House Clinical and Imaging Centers
CategoryClinical Research Services
Description

Dedicated in-house clinical and imaging facilities enabling Perceptive to conduct imaging and early-phase clinical studies directly for sponsors, with full control over imaging protocols and study execution.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-27
Description

Perceptive eClinical and Trialzen announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled clinical supply consultancy service that combines Perceptive's randomization and supply optimization expertise with Trialzen's advanced forecasting and simulation technologies. The service addresses industry inefficiency where approximately 50% of clinical finished goods manufactured for trials are never administered to patients. Engagements reportedly generate savings exceeding $1 million per study and are fully integrated into Perceptive's ClinPhone Pro platform.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-15
Description

Perceptive Discovery announced a strategic partnership with MH3D and launched α-Sight, a preclinical imaging service enabling direct in vivo visualization of alpha-emitting radiopharmaceuticals. The offering integrates MH3D's Alpha-SPECT Mini CZT-based detection platform with Perceptive Discovery's preclinical imaging, radiochemistry, and quantitative image analysis expertise. Perceptive Discovery serves as MH3D's exclusive service provider. α-Sight supports biodistribution studies, tumor targeting validation, and PK/PD assessment to help accelerate radioligand therapy development programs.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-24
Description

Perceptive eClinical and Kayentis formed a strategic partnership to deliver an integrated eCOA-IRT solution for clinical trials. The partnership addresses industry challenge of digital system fragmentation where sites often use up to 17 different systems in a single study. The joint offering combines Perceptive's Interactive Response Technology expertise with Kayentis' electronic Clinical Outcome Assessment capabilities to streamline trial execution, reduce site workload, and lower study costs through automatic data transfer and workflow integration. Both companies view this as the beginning of broader interoperability expansion across the clinical trial lifecycle.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

The largest global CRO and life sciences technology vendor. Overlaps directly with Perceptive in clinical trial imaging, IRT/RTSM, and preclinical-to-Phase III execution, but operates as a full-service, broad-portfolio incumbent rather than an imaging- and eClinical-focused specialist.

TypeBroad incumbent
Description

Top-five global CRO following the PRA Health Sciences merger, with significant imaging core lab, RTSM, and clinical operations capabilities. Comparable because it competes for the same enterprise pharma imaging and eClinical contracts as Perceptive, though at much larger scale.

TypeBroad incumbent
Description

Broad clinical laboratory and CRO services business (with Fortrea spun out as a focused CRO). Comparable to Perceptive in central lab, imaging, and trial supply management, though it spans diagnostic testing, routine labs, and drug development.

TypeBroad incumbent
Description

Large global CRO (private-equity-owned) with full-service clinical, biostatistics, and RTSM offerings. Competes with Perceptive for enterprise sponsor imaging and randomization contracts and shares the same end customers.

TypeDirect peer
Description

Mid-sized, profitable CRO focused on small-to-mid biotech sponsors across all phases. Overlaps with Perceptive in clinical operations, imaging, and lab services, and is one of the most directly comparable CRO peers in terms of sponsor mix and therapeutic focus.

TypeDirect peer
Description

Specialty provider of clinical trial endpoint technologies including eCOA, cardiac safety, and imaging core lab services. Direct competitor to Perceptive Imaging and to ClinPhone Pro in eClinical, with deep scientific expertise in imaging endpoints.

TypeBroad incumbent
Description

Cloud platform provider for life sciences, with Veeva Vault CDMS, eTMF, and clinical operations software used by the same sponsors Perceptive serves. Adjacent and partially overlapping with ClinPhone Pro and Perceptive's eClinical roadmap.

TypeDirect peer
Description

Major preclinical CRO with discovery, safety assessment, and imaging services. Comparable to Perceptive Discovery on the preclinical imaging and radiochemistry side and overlaps in early-stage oncology and CNS sponsors.

TypeDirect peer
Description

Long-standing imaging core lab for oncology and CNS trials, now part of Clario. One of Perceptive's closest direct competitors in clinical trial imaging, particularly in oncology and neurodegenerative disease programs.

TypeEmerging player
Description

Specialty RTSM/IRT vendor competing with ClinPhone Pro. Comparable as a focused eClinical randomization vendor and a peer in Everest Group's RTSM PEAK Matrix alongside Perceptive.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Perceptive

Clinical Research Servicesperceptive.com

Perceptive is a London-based clinical research services provider offering preclinical imaging, clinical trial imaging, and IRT/RTSM solutions to global biopharmaceutical sponsors and CROs, with deep specialization in radiopharmaceutical therapy and oncology.

What Perceptive does

Perceptive is a privately held, science-led clinical research services provider headquartered in London, with operations spanning preclinical imaging, clinical trial imaging, and randomization and trial supply management (RTSM). The company is organized into three operating divisions — Perceptive Discovery (preclinical imaging, radiochemistry, biodistribution, and binding assays), Perceptive eClinical (IRT/RTSM, with the ClinPhone Pro platform, plus eCOA and Clinical Intelligence), and Perceptive Imaging (imaging core lab and in-house imaging centers in London and New Haven). Its technology stack combines proprietary software (VivoQuant for preclinical image analysis, ClinPhone Pro for cloud-native RTSM, and iPACS for workflow management) with multi-modality imaging capabilities across PET, SPECT, MRI, CT, and optical platforms, and GMP radiotracer manufacturing.

The company serves global biopharmaceutical sponsors and CROs, with a strong specialty focus on radiopharmaceutical therapy and theranostics (supporting 80% of radioligand therapy companies), oncology (1,800+ solid tumor trials), CNS (770+ trials), and rare diseases. It has supported 11,000+ trials, 800+ regulatory approvals across FDA, EMA, and NMPA, and randomized 3M+ participants through its IRT systems. Named customers include ArriVent, LG Chem, Veralox Therapeutics, ClinChoice, and ProTrials. Distribution is enterprise-direct with CRO channel partnerships, and services are quote-based professional engagements plus recurring platform subscriptions on ClinPhone Pro.

Revenue is not publicly disclosed. Growth is being driven by a cluster of recent moves: the May 2025 launch of ClinPhone Pro, a January 2026 $15M investment from CapVest, and 2026 alliances with Trialzen (clinical supply intelligence), Kayentis (eCOA), and MH3D (α-Sight alpha radiopharmaceutical imaging), alongside a 5x expansion of its Needham preclinical lab. The company maintains a zero-observation regulatory inspection record over the past decade and is recognized as the #1 Market Impact leader in Everest Group's 2025 PEAK Matrix for RTSM Solutions.

Perceptive firmographics

Firmographics
Name
Perceptive
Legal name
Perceptive
Website
https://perceptive.com
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Perceptive is a London-based clinical research services provider offering preclinical imaging, clinical trial imaging, and IRT/RTSM solutions to global biopharmaceutical sponsors and CROs, with deep specialization in radiopharmaceutical therapy and oncology.
Ownership category
akta.pro rank

Perceptive industry classification

Industry
Product category
Clinical Research Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Clinical trial imaging
  • Preclinical imaging services
  • Randomization trial supply
  • Medical imaging core lab
  • Radiochemistry services

Where Perceptive is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices5 records

Markets served

Perceptive business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Clinical Imaging Core Lab Services: Fees for clinical trial imaging services including centralized blinded independent reads, quantitative image analysis, site qualification and training, and regulatory-compliant data management across all phases of clinical development.
  2. IRT/RTSM Technology and Services: Interactive Response Technology platform and randomization services for clinical trials, supporting all phases and therapeutic areas with dedicated project management and consultancy.
  3. Preclinical Imaging and Radiochemistry Services: Discovery-phase imaging services including biodistribution studies, efficacy modeling, dosimetry, and radiolabeling services for drug development programs.
  4. Clinical Intelligence Consultancy: Technology-enabled consultancy service combining clinical supply expertise with advanced forecasting technology, generating reported savings exceeding $1 million per study for sponsors.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Perceptive product offering

Product offering

Core offering

Perceptive delivers preclinical and clinical medical imaging core lab services, randomization and trial supply management (IRT/RTSM) via the ClinPhone Pro platform, electronic clinical outcome assessments (eCOA), radiochemistry, biodistribution and radioligand binding assay services, and clinical trial adjudication for pharmaceutical, biotechnology, and medical device sponsors. The company supports more than 11,000 trials and 800 regulatory approvals with a workforce of 3,000+ professionals across its integrated preclinical-to-clinical continuum.

Product overview

Perceptive is a science-led provider offering preclinical imaging, clinical trial imaging, and randomization and trial supply management (RTSM) services. The company's product portfolio consists of three interconnected service pillars: (1) Discovery/Preclinical services including Preclinical Imaging, Radiochemistry, Biodistribution Services, and Radioligand Binding Assay Services; (2) eClinical solutions including IRT/RTSM (ClinPhone Pro platform), eCOA module, and Clinical Intelligence consultancy; and (3) Clinical Imaging services including Imaging Core Lab and In-House Clinical and Imaging Centers. Supporting these core offerings is the VivoQuant™ software platform for preclinical image analysis. The integrated ecosystem enables sponsors to move from early discovery through late-phase clinical trials, with specialized expertise in oncology, CNS, radiopharmaceutical therapy, and rare diseases.

Differentiator

Problem solved

Functional benefit

Brands

  • ClinPhone Pro: Next-generation IRT/RTSM platform for clinical trial randomization and supply management
  • VivoQuant™
  • Perceptive Clinical Intelligence
  • α-Sight™

Products and services

  • Clinical Imaging Core Lab Centralized medical imaging core lab services for clinical trials, including image acquisition standards, blinded independent central review, and quantitative endpoint analysis for pharmaceutical and biotech sponsors across therapeutic areas including oncology.
  • Preclinical Imaging Preclinical imaging services and image analysis software (VivoQuant) supporting early-stage drug development, biodistribution studies, and translational research for pharmaceutical and biotech R&D teams.
  • IRT/RTSM (ClinPhone Pro) Randomization and Trial Supply Management (IRT/RTSM) software platform used to randomize patients, manage drug supply logistics, and maintain blinding in clinical trials for pharmaceutical and biotech sponsors.
  • Electronic Clinical Outcome Assessment (eCOA) Electronic Clinical Outcome Assessment platform for capturing patient-reported outcomes, clinician-reported outcomes, and performance outcomes in clinical trials, deployed for pharmaceutical and biotech sponsors.
  • Radiochemistry Services Specialized radiochemistry services supporting the development and manufacture of radiolabeled compounds for imaging and radioligand therapy studies in clinical and preclinical development.
  • Biodistribution Services Biodistribution studies and analyses, including quantitative tissue distribution assessments, supported by the α-Sight workflow tool, for sponsors developing radiopharmaceuticals and imaging agents.
  • Radioligand Binding Assay Services Radioligand binding assay services supporting in vitro characterization of receptor-ligand interactions for radiopharmaceutical and central nervous system drug development programs.
  • Clinical Trial Adjudication Services Independent endpoint adjudication committee management and event adjudication services for clinical trials requiring blinded expert review of safety or efficacy events.
  • In-House Clinical and Imaging Centers Dedicated in-house clinical and imaging facilities enabling Perceptive to conduct imaging and early-phase clinical studies directly for sponsors, with full control over imaging protocols and study execution.

Quantifiable outcome

  • Real-world engagements generating savings exceeding $1 million per study through clinical supply optimization
  • +4 more outcomes

Companies that use Perceptive

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Perceptive technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature5 records

Perceptive partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • TrialzencoreStrategic or Co-development Partner · 27 April 2026Perceptive eClinical and Trialzen announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled clinical supply consultancy service that combines Perceptive's randomization and supply optimization expertise with Trialzen's advanced forecasting and simulation technologies. The service addresses industry inefficiency where approximately 50% of clinical finished goods manufactured for trials are never administered to patients. Engagements reportedly generate savings exceeding $1 million per study and are fully integrated into Perceptive's ClinPhone Pro platform.
  • MH3DcoreTechnology or Integration · 15 April 2026Perceptive Discovery announced a strategic partnership with MH3D and launched α-Sight, a preclinical imaging service enabling direct in vivo visualization of alpha-emitting radiopharmaceuticals. The offering integrates MH3D's Alpha-SPECT Mini CZT-based detection platform with Perceptive Discovery's preclinical imaging, radiochemistry, and quantitative image analysis expertise. Perceptive Discovery serves as MH3D's exclusive service provider. α-Sight supports biodistribution studies, tumor targeting validation, and PK/PD assessment to help accelerate radioligand therapy development programs.
  • KayentiscoreStrategic or Co-development Partner · 24 March 2026Perceptive eClinical and Kayentis formed a strategic partnership to deliver an integrated eCOA-IRT solution for clinical trials. The partnership addresses industry challenge of digital system fragmentation where sites often use up to 17 different systems in a single study. The joint offering combines Perceptive's Interactive Response Technology expertise with Kayentis' electronic Clinical Outcome Assessment capabilities to streamline trial execution, reduce site workload, and lower study costs through automatic data transfer and workflow integration. Both companies view this as the beginning of broader interoperability expansion across the clinical trial lifecycle.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Perceptive competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: The largest global CRO and life sciences technology vendor. Overlaps directly with Perceptive in clinical trial imaging, IRT/RTSM, and preclinical-to-Phase III execution, but operates as a full-service, broad-portfolio incumbent rather than an imaging- and eClinical-focused specialist.
  • ICON plc: Top-five global CRO following the PRA Health Sciences merger, with significant imaging core lab, RTSM, and clinical operations capabilities. Comparable because it competes for the same enterprise pharma imaging and eClinical contracts as Perceptive, though at much larger scale.
  • Labcorp (incl. Covance/Fortrea): Broad clinical laboratory and CRO services business (with Fortrea spun out as a focused CRO). Comparable to Perceptive in central lab, imaging, and trial supply management, though it spans diagnostic testing, routine labs, and drug development.
  • Parexel International: Large global CRO (private-equity-owned) with full-service clinical, biostatistics, and RTSM offerings. Competes with Perceptive for enterprise sponsor imaging and randomization contracts and shares the same end customers.
  • Veeva Systems: Cloud platform provider for life sciences, with Veeva Vault CDMS, eTMF, and clinical operations software used by the same sponsors Perceptive serves. Adjacent and partially overlapping with ClinPhone Pro and Perceptive's eClinical roadmap.

Direct peers

  • Medpace: Mid-sized, profitable CRO focused on small-to-mid biotech sponsors across all phases. Overlaps with Perceptive in clinical operations, imaging, and lab services, and is one of the most directly comparable CRO peers in terms of sponsor mix and therapeutic focus.
  • Clario (formerly ERT/Bioclinica): Specialty provider of clinical trial endpoint technologies including eCOA, cardiac safety, and imaging core lab services. Direct competitor to Perceptive Imaging and to ClinPhone Pro in eClinical, with deep scientific expertise in imaging endpoints.
  • Charles River Laboratories: Major preclinical CRO with discovery, safety assessment, and imaging services. Comparable to Perceptive Discovery on the preclinical imaging and radiochemistry side and overlaps in early-stage oncology and CNS sponsors.
  • BioClinica (now part of Clario): Long-standing imaging core lab for oncology and CNS trials, now part of Clario. One of Perceptive's closest direct competitors in clinical trial imaging, particularly in oncology and neurodegenerative disease programs.

Emerging players

  • 4G Clinical: Specialty RTSM/IRT vendor competing with ClinPhone Pro. Comparable as a focused eClinical randomization vendor and a peer in Everest Group's RTSM PEAK Matrix alongside Perceptive.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Perceptive social profiles

Digital presence

Perceptive financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Perceptive leadership team

Management profile

Number of profiles

Perceptive funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Perceptive M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Perceptive

What does Perceptive do?

Perceptive delivers preclinical and clinical medical imaging core lab services, randomization and trial supply management (IRT/RTSM) via the ClinPhone Pro platform, electronic clinical outcome assessments (eCOA), radiochemistry, biodistribution and radioligand binding assay services, and clinical trial adjudication for pharmaceutical, biotechnology, and medical device sponsors. The company supports more than 11,000 trials and 800 regulatory approvals with a workforce of 3,000+ professionals across its integrated preclinical-to-clinical continuum.

Is Perceptive a public or private company?

Perceptive is a private company. It is classified as private equity controlled and is currently operating.

When was Perceptive founded?

Perceptive was founded in 1995. It employs 1,001 to 5,000 people.

Where is Perceptive based?

Perceptive is headquartered in London, United Kingdom, in the Europe region.

How does Perceptive make money?

Four revenue lines are on record. Clinical Imaging Core Lab Services are the primary driver. The others are IRT/RTSM Technology and Services, preclinical Imaging and Radiochemistry Services and clinical Intelligence Consultancy.

Who are Perceptive's main competitors?

Broad incumbents on record are IQVIA, ICON plc, Labcorp (incl. Covance/Fortrea), Parexel International and Veeva Systems. Direct peers are Medpace, Clario (formerly ERT/Bioclinica), Charles River Laboratories and BioClinica (now part of Clario). 4G Clinical is listed as an emerging player.

Does Perceptive have an API?

No public API is recorded for Perceptive.

What industry is Perceptive in?

Perceptive's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAK, Real-World Evidence (RWE), HEOR & Epidemiology CROs, with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePerceptive Discovery Appoints Dr. Benjamin Bronfin as Vice President of Operations to Support Continued Growth and Operational ExcellencePerceptive Discovery appointed Dr. Benjamin Bronfin as Vice President of Operations to lead operational efficiency and service delivery. He brings over 25 years of CRO and biotech leadership experience, including roles at Pharmaron and Cambridge Biomedical. The appointment aims to support growth in oncology and radioligand therapy drug development.PR NewswirePerceptive Discovery Launches Astatine-211 Study Capabilities in the US and UKPerceptive Discovery announced availability of astatine-211 radiopharmaceutical development studies at its US and UK locations, becoming the first US provider to execute such studies. The company installed an Atley C100 module at Queen Mary University of London and plans a second at its Needham, Massachusetts facility. It is now accepting inquiries for At-211 development programs.PR NewswirePerceptive Discovery and Nucleus RadioPharma Announce Strategic Partnership to Accelerate Radiopharmaceutical Development from Target to ClinicPerceptive Discovery and Nucleus RadioPharma announced a strategic partnership to accelerate radiopharmaceutical development from preclinical imaging to clinical manufacturing. The non-exclusive agreement connects their complementary capabilities, aiming to reduce time, cost, and friction at the handoff. The companies will review performance and expand the collaboration over time.Built In15 Biotech Companies in Boston to Know in 2026The article presents a list of biotech companies based in Boston, highlighting their specific technological focuses and market roles. It details the operations of Emulate, which develops organ-on-a-chip technology for drug safety testing; Perceptive, providing imaging analytics for drug discovery; and Gradient, an environmental health consulting firm.PR NewswirePerceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with TrialzenPerceptive eClinical and Trialzen announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled consultancy service that combines Perceptive's clinical supply expertise with Trialzen's advanced planning and simulation technologies. The service aims to address industry inefficiency where approximately 50% of clinical finished goods manufactured for trials are never administered to patients, representing hundreds of millions of dollars in wasted drug supply. The alliance enables sponsors to access integrated forecasting and supply optimization tools through Perceptive's Clinphone Pro platform, with the companies reporting real-world engagements generating savings exceeding $1 million.ThemalaysianreservePerceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with TrialzenPerceptive eClinical and Trialzen announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled clinical supply consultancy service that integrates Perceptive's randomization and clinical supply optimization expertise with Trialzen's advanced forecasting and simulation technologies. The service aims to address industry-wide inefficiency, with benchmarks showing approximately 50% of clinical finished goods manufactured for trials are never administered to patients, representing hundreds of millions of dollars in wasted drug supply. The consultancy, built on 30 years of Perceptive's in-house experience, will be fully integrated into Perceptive's Clinphone Pro platform and targets sponsors across oncology, endocrinology, infectious diseases, and emerging areas such as cell and gene therapies.PR NewswirePerceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with TrialzenPerceptive eClinical and Trialzen announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled clinical supply consultancy service that combines Perceptive's randomization and supply optimization expertise with Trialzen's advanced forecasting and simulation technologies. The service addresses a significant industry problem, with industry data showing approximately 50% of Clinical Finished Goods manufactured for clinical trials are never administered to patients, representing hundreds of millions of dollars in wasted drug supply each year. The alliance enables sponsors to move from scenario planning to operational action in a single integrated environment, with engagements reportedly generating savings exceeding $1 million per study.Eqs-newsPerceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with TrialzenPerceptive eClinical and Trialzen have announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled clinical supply consultancy service that combines Perceptive's randomization and supply optimization expertise with Trialzen's advanced forecasting and simulation technologies. The service addresses the industry problem where approximately 50% of clinical finished goods manufactured for trials are never administered to patients, representing hundreds of millions of dollars in wasted drug supply annually. The companies report that real-world engagements have generated savings exceeding $1 million and materially reduced supply overage for sponsors.YahooPerceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with TrialzenPerceptive eClinical and Trialzen announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled clinical supply consultancy service that combines Perceptive's randomization and clinical supply expertise with Trialzen's advanced planning and analytics technologies. The service aims to help sponsors design, stress test, and manage clinical supply strategies across the entire clinical trial lifecycle, addressing what the companies call a significant industry problem. Industry benchmarks cited indicate approximately 50% of clinical finished goods manufactured for trials are never administered to patients, with the companies claiming real-world engagements have generated savings exceeding $1 million.YahooPerceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with TrialzenPerceptive eClinical, a provider of interactive response technology and eClinical solutions, has launched a new Clinical Intelligence Consultancy Service in alliance with Trialzen, a clinical supply forecasting technology company, to offer integrated clinical supply strategy across the trial lifecycle. The combined offering leverages Perceptive's randomization and supply management expertise alongside Trialzen's mathematical modeling and simulation engine, integrated into Perceptive's Clinphone Pro platform, with the companies reporting that real-world engagements have generated savings exceeding $1 million. Industry data cited indicates that approximately 50% of clinical finished goods manufactured for trials are never administered to patients, representing hundreds of millions of dollars in wasted drug supply annually.